Antimetabolites: all 7,305 studies that test it
Page 56 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- T-cell Based Immunotherapy for of MelanomaCompletedNCT00937625Phase 1/2
- Aminopterin Pharmacokinetic Study In Moderate to Severe PsoriasisCompletedNCT00937027Phase 1
- Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryWithdrawnNCT00936832Phase 2
- Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion ChemotherapyCompletedNCT00933816Phase 1/2
- Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's DiseaseStatus unknownNCT00931957Not applicable
- A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic LeukaemiaCompletedNCT00930098Phase 2
- The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement ProcessesStatus unknownNCT00926900Phase 2/3
- GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the ElderlyCompletedNCT00925873Phase 3
- Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung CancerStatus unknownNCT00923637Phase 2
- Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic SyndromesTerminatedNCT00923234Phase 1
- XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNCT00920868Phase 1
- A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis PatientsWithdrawnNCT00920608Phase 1
- Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin LymphomaTerminatedNCT00920153Phase 3
- Gemcitabine (GFF) in Patients With Pancreatic CancerCompletedNCT00919282Phase 2
- Efficacy Study of Methotrexate to Treat Sarcoid-associated UveitisTerminatedNCT00918554Phase 4
- Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)CompletedNCT00916630Phase 1
- Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and ThymoglobulinTerminatedNCT00915811Phase 2
- Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic AbnormalitiesCompletedNCT00915785Phase 2
- Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOSCompletedNCT00915382Phase 3
- Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)CompletedNCT00915252Phase 2
- A Study of CP-4126 in Patients With Advanced Pancreatic CancerCompletedNCT00913198Phase 2
- MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic LeukemiaCompletedNCT00911066Phase 1
- Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer RectumCompletedNCT00909987Phase 2
- Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin LymphomaStatus unknownNCT00908180Phase 2
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesCompletedNCT00908167Phase 1
- Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin LymphomaStatus unknownNCT00907036Phase 2
- Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00906061Phase 2
- Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00905983Phase 2
- Low Dose Cyclosporin and Methotrexate Therapy in DiabetesCompletedNCT00905073Not applicable
- Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal CancerCompletedNCT00905047Phase 3
- Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive MeningiomaStatus unknownNCT00904735Phase 2
- Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung AdenocarcinomaStatus unknownNCT00903292Not applicable
- Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced SarcomaActive, not recruitingNCT00902044Phase 1
- The Chinese University of Hong Kong Early Arthritis StudyCompletedNCT00901550Not applicable
- Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck CancerTerminatedNCT00901537Phase 1
- 5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)CompletedNCT00897130Phase 2
- Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for MesotheliomaTerminatedNCT00895648Phase 2
- Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT00891579Phase 2
- Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.CompletedNCT00890500Phase 1
- Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AMLStatus unknownNCT00887042Phase 1/2
- A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)Status unknownNCT00886678Phase 2
- 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular CorrelatesTerminatedNCT00886457Phase 1
- A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung CancerTerminatedNCT00885963Phase 2
- Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)CompletedNCT00885833Phase 1/2
- Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00885066Phase 1
- Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced AdenocarcinomaCompletedNCT00883480Not applicable
- Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)Status unknownNCT00882323Phase 2
- Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasTerminatedNCT00882076Phase 1
- Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric CarcinomaStatus unknownNCT00881816Phase 1
- Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)TerminatedNCT00881556Early Phase 1
- Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to TreatmentWithdrawnNCT00881387Phase 2
- Gemcitabine and Carboplatin for Elderly Patient With Lung CancerCompletedNCT00881296Phase 2
- Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell TransplantCompletedNCT00880815Phase 1
- KRAS Wild-type Metastatic Colorectal Cancer TrialCompletedNCT00879385Phase 1
- Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic CancerTerminatedNCT00878657Phase 1
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by SurgeryActive, not recruitingNCT00878163Phase 1
- Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer PatientsCompletedNCT00875771Phase 2
- A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)CompletedNCT00875693Phase 1
- A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00874328Phase 1/2
- Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer PatientsCompletedNCT00873353Phase 2
- Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal CancerCompletedNCT00873275Phase 1
- Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach AdenocarcinomaTerminatedNCT00871273Phase 4
- Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for DepressionCompletedNCT00869765Phase 2
- External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00869570Phase 1/2
- Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck CancerCompletedNCT00868491Phase 2
- Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid LeukemiaCompletedNCT00867672Phase 2
- Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid LeukemiaCompletedNCT00866073Phase 2
- Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal CancerStatus unknownNCT00865982Phase 2
- Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With SchizophreniaCompletedNCT00864825Phase 4
- A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00861874Phase 1
- Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver MetastasesCompletedNCT00858429Phase 1
- Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach CancerCompletedNCT00858338Phase 2
- Virtual Reality and D-Cycloserine in Combat Related Psycological Trauma in Burn Service MembersWithdrawnNCT00855153Not applicable
- Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic AdenocarcinomaCompletedNCT00854477Phase 4
- Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute LeukemiasTerminatedNCT00852709Phase 1
- Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan RegimenCompletedNCT00852163Phase 2
- Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic TrioxideCompletedNCT00850304Phase 2
- Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNCT00849550Phase 1
- Azathioprine & Allopurinol in Inflammatory Bowel Disease PatientsCompletedNCT00849368Phase 1
- Xeloda and Bevacizumab to Treat Rectal CancerCompletedNCT00847119Phase 2
- Thyroid Disease in Pregnancy: Case Finding Versus Universal ScreeningCompletedNCT00846755Not applicable
- The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic LeukemiaStatus unknownNCT00846703Phase 4
- Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric CancerStatus unknownNCT00845884Phase 1/2
- Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWithdrawnNCT00845104Phase 2
- Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00844688Phase 2
- Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II StudyStatus unknownNCT00842686Phase 2
- Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical CancerStatus unknownNCT00842660Phase 3
- Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian CancerWithdrawnNCT00842582Phase 1
- Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric CancerCompletedNCT00842491Phase 2
- Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00840684Phase 1/2
- Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00838656Phase 2
- Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With FluoropyrimidinesCompletedNCT00838370Phase 1
- Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk MyelodysplasiaStatus unknownNCT00838240Phase 1/2
- Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract CancerCompletedNCT00832689Phase 2
- A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian CancerCompletedNCT00831636Phase 1/2
- Lenalidomide and Decitabine in High Grade Myelodysplastic SyndromesCompletedNCT00828802Phase 1
- Eniluracil Hand Foot SyndromeTerminatedNCT00827580Phase 1
- D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)WithdrawnNCT00827281Phase 2
- REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG CancerTerminatedNCT00824785Phase 3
- Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesCompletedNCT00824135Phase 1